Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Vera H. M. Deneer"'
Autor:
Manon G. den Uil, Hannelotte W. Hut, Kay R. Wagelaar, Heshu Abdullah-Koolmees, Wiepke Cahn, Ingeborg Wilting, Vera H. M. Deneer
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Introduction: Preventing side effects is important to ensure optimal psychopharmacotherapy and therapeutic adherence among psychiatric patients. Obtaining the pharmacogenetic profile of CYP2C19 and CYP2D6 can play an important role in this. When the
Externí odkaz:
https://doaj.org/article/3defa2258bf84c2cace1a461959d62b2
Autor:
Corine de Jong, Gerarda J. M. Herder, Simone W. A. van Haarlem, Femke S. van der Meer, Anne S. R. van Lindert, Alexandra ten Heuvel, Jan Brouwer, Toine C. G. Egberts, Vera H. M. Deneer
Publikováno v:
Genes, Vol 14, Iss 1, p 170 (2023)
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, disabling side effect in non-small cell lung cancer (NSCLC) patients treated with platinum-based therapy. There is increasing evidence for associations between genetic variant
Externí odkaz:
https://doaj.org/article/2beffaa37dac4e7aacb747e8bb44f21a
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Many studies have shown that the efficacy and risk of side effects of drug treatment is influenced by genetic variants. Evidence based guidelines are essential for implementing pharmacogenetic knowledge in daily clinical practice to optimize pharmaco
Externí odkaz:
https://doaj.org/article/8bb649b16119415297be57b15561df90
Autor:
Zulfan Zazuli, Corine de Jong, Wei Xu, Susanne J. H. Vijverberg, Rosalinde Masereeuw, Devalben Patel, Maryam Mirshams, Khaleeq Khan, Dangxiao Cheng, Bayardo Ordonez-Perez, Shaohui Huang, Anna Spreafico, Aaron R. Hansen, David P. Goldstein, John R. de Almeida, Scott V. Bratman, Andrew Hope, Jennifer J. Knox, Rebecca K. S. Wong, Gail E. Darling, Abhijat Kitchlu, Simone W. A. van Haarlem, Femke van der Meer, Anne S. R. van Lindert, Alexandra ten Heuvel, Jan Brouwer, Colin J. D. Ross, Bruce C. Carleton, Toine C. G. Egberts, Gerarda J. M. Herder, Vera H. M. Deneer, Anke H. Maitland-van der Zee, Geoffrey Liu
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 11, p 1233 (2021)
This study aims to evaluate genetic risk factors for cisplatin-induced nephrotoxicity by investigating not previously studied genetic risk variants and further examining previously reported genetic associations. A genome-wide study (GWAS) was conduct
Externí odkaz:
https://doaj.org/article/7373dee5fa83488bb27f8905750962c7
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
IntroductionThe Dutch Pharmacogenetics Working Group (DPWG) indicated a list of actionable genotypes that affect patients’ response to more 50 drugs; these drugs which show variable effects based on patients’ genetic traits were named as pharmaco
Externí odkaz:
https://doaj.org/article/fc7ee493cd844a5d9c16fec8067c7819
Autor:
Thomas O. Bergmeijer, Alfi Yasmina, Gerrit J. A. Vos, Paul W. A. Janssen, Christian M. Hackeng, Johannes C. Kelder, Shefali S. Verma, Marylyn D. Ritchie, Li Gong, Teri E. Klein, ICPC investigators, Anthonius de Boer, Olaf H. Klungel, Jurriën M. ten Berg, Vera H. M. Deneer
Publikováno v:
Genes, Vol 11, Iss 9, p 1068 (2020)
This study aims to determine whether genetic variants that influence CYP3A4 expression are associated with platelet reactivity in clopidogrel-treated patients undergoing elective percutaneous coronary intervention (PCI), and to evaluate the influence
Externí odkaz:
https://doaj.org/article/eefa6e9164df44d191994a7059b0b403
Autor:
Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne-Marie Buunk, Henk Jan Guchelaar, Elisa J. F. Houwink, Arne Risselada, Gerard A. P. J. M. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Roos van Westrhenen, Vera H. M. Deneer, Jan van der Weide
Publikováno v:
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate pharmacogenetics implementation in clinical practice by developing evidence-based guidelines to optimize pharmacotherapy. A guideline describing the gene-drug interaction between the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d87804d4af6dcbaf1b5d9f3f194979
https://cris.maastrichtuniversity.nl/en/publications/8434c9e0-c985-4bc8-a492-71fb47e9fdc5
https://cris.maastrichtuniversity.nl/en/publications/8434c9e0-c985-4bc8-a492-71fb47e9fdc5
Autor:
Emma C. Hulshof, Maarten J. Deenen, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne-Marie Buunk, Elisa J. F. Houwink, Arne Risselada, Gerard A. P. J. M. Rongen, Ron H. N. van Schaik, Daan J. Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Henk-Jan Guchelaar, Jesse J. Swen
Publikováno v:
European Journal of Human Genetics.
Autor:
Marga Nijenhuis, Bianca Soree, Wafa O. M. Jama, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Elisa J. F. Houwink, Gerard A. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Arne Risselada
Publikováno v:
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics
European Journal of Human Genetics. Nature Publishing Group
Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite progress in the field. To promote implementation, the Dutch Pharmacogenetics Working Group (DPWG) develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f755520f566484b90f85d4cb382e207
http://hdl.handle.net/1887/3515272
http://hdl.handle.net/1887/3515272
Autor:
Emma C. Hulshof, Maarten J. Deenen, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne-Marie Buunk, Elisa J. F. Houwink, Arne Risselada, Gerard A. P. J. M. Rongen, Ron H. N. van Schaik, Daan J. Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Henk-Jan Guchelaar, Jesse J. Swen
Publikováno v:
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics
The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy. This guideline describes the starting dose optimization of the anti-cancer dru